AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
154 hedge funds and large institutions have $2.59B invested in Aegerion Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 59
Holders
154
Holding in Top 10
4
Calls
$204M
Puts
$165M
Top Buyers
| 1 | +$60.8M | |
| 2 | +$53.7M | |
| 3 | +$41.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$38.8M |
Top Sellers
| 1 | -$107M | |
| 2 | -$70.8M | |
| 3 | -$69.9M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$28.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$20M |